# Amgen Inc. (AMGN) — Q3-2011 Earnings Results

**Report date:** 2011-10-24 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2011

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.61%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.40 | N/A | +10.67% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's financial health. They highlighted the importance of maintaining a strong EPS as a positive indicator.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They emphasized a focus on long-term growth strategies.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a positive surprise in EPS, which contributed to a slight increase in the stock price. The lack of revenue data and guidance may leave some investors cautious, but the EPS beat suggests the company is managing its costs effectively. The stock's modest gain reflects a generally favorable reception to the earnings news.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2011_